Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
Jupiter is actively exploring additional strategic partnerships to expand JOTROL’s application across other neuroinflammatory and metabolic disorders, including Alzheimer’s disease and longevity ...
Jupiter Neurosciences, Inc.: Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based ...
Jupiter Neurosciences partners with Zina for Parkinson's trial
JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company with a market capitalization of $40.39 million, has announced a strategic partnership with Zina ...
Ever-Growing USA on MSN22h
AquaSculpt’s “Ice Water Hack”: Revolutionary Weight Loss or Just Hype?
In a world overwhelmed with conflicting information about weight loss, AquaSculpt emerges as a beacon of hope for those ...
The American Journal of Managed Care2h
Resveratrol Oral Supplement Associated With Lower Rates of Intravitreal Aflibercept Injections
Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...